Sigyn Therapeutics, Inc.
SIGY
Revenue
3.83k
▲3.08k▲407.14%
6 Months ChangeAssets
427.44k
▲107.27k▲33.51%
3 Months ChangeLiabilities
4.35M
▲357.72k▲8.96%
3 Months ChangeFree Cash Flow
-277.30k
▼-168.86k▼-155.73%
48 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-16
Form 8-K
ID: 0001493152-24-041287
2024-10-07
Form 8-K
ID: 0001493152-24-039594
2024-08-19
Form 10-Q
ID: 0001493152-24-033048
2024-06-06
Form 8-K
ID: 0001493152-24-022945
2024-05-15
Form 8-K
ID: 0001493152-24-020007
2024-05-14
Form 10-Q
ID: 0001493152-24-019221
2024-04-16
Form 8-K
ID: 0001493152-24-014866
2024-01-31
Form 8-K
ID: 0001493152-24-004502
2024-01-30
Form 8-K
ID: 0001493152-24-004320
2024-01-11
Form 8-K
ID: 0001493152-24-002048